Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E H Gerlach

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Journal of Clinical Microbiology|December 1, 1979
Methods of measuring zones of inhibition with the Bauer-Kirby disk susceptibility testA L Barry, M B Coyle, C Thornsberry, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1994
Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test mediumG V Doern, R N Jones, E H Gerlach, et al.
European Journal of Clinical Microbiology|June 1, 1984
In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centersA L Barry, L W Ayers, T L Gavan, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1990
Sucralfate significantly reduces ciprofloxacin concentrations in serumJ C Garrelts, P J Godley, J D Peterie, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1993
In vitro comparison of E4868, a new trifluoroquinolone, with ciprofloxacin and temafloxacin tested against 5192 recent clinical isolates from five medical centersP R Murray, R N Jones, J A Washington, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1991
Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolatesP C Fuchs, A L Barry, M A Pfaller, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1985
In vitro comparative antimicrobial activity of cefpimizole against clinical isolates from five medical centersR N Jones, L W Ayers, T L Gavan, et al.
Journal of Clinical Microbiology|January 1, 1978
Serotyping herpes simplex virus isolated by enzyme-linked immunosorbent assaysK W Mills, E H Gerlach, J W Bell, et al.
The Journal of Antibiotics|July 1, 1977
BL-S786, a new parenteral cephalosporin. I. A collaborative in vitro susceptibility comparison to cephalothin against 5,762 clinical bacterial isolatesR N Jones, P C Fuchs, T L Gavan, et al.
Journal of Clinical Microbiology|December 1, 1979
Simple inoculum standardizing system for antimicrobial disk susceptibility testsA L Barry, D Amsterdam, M B Coyle, et al.
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Journal of Clinical Microbiology|December 1, 1979
Methods of measuring zones of inhibition with the Bauer-Kirby disk susceptibility testA L Barry, M B Coyle, C Thornsberry, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1994
Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test mediumG V Doern, R N Jones, E H Gerlach, et al.
European Journal of Clinical Microbiology|June 1, 1984
In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centersA L Barry, L W Ayers, T L Gavan, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1990
Sucralfate significantly reduces ciprofloxacin concentrations in serumJ C Garrelts, P J Godley, J D Peterie, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1993
In vitro comparison of E4868, a new trifluoroquinolone, with ciprofloxacin and temafloxacin tested against 5192 recent clinical isolates from five medical centersP R Murray, R N Jones, J A Washington, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1991
Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolatesP C Fuchs, A L Barry, M A Pfaller, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1985
In vitro comparative antimicrobial activity of cefpimizole against clinical isolates from five medical centersR N Jones, L W Ayers, T L Gavan, et al.
Journal of Clinical Microbiology|January 1, 1978
Serotyping herpes simplex virus isolated by enzyme-linked immunosorbent assaysK W Mills, E H Gerlach, J W Bell, et al.
The Journal of Antibiotics|July 1, 1977
BL-S786, a new parenteral cephalosporin. I. A collaborative in vitro susceptibility comparison to cephalothin against 5,762 clinical bacterial isolatesR N Jones, P C Fuchs, T L Gavan, et al.
Journal of Clinical Microbiology|December 1, 1979
Simple inoculum standardizing system for antimicrobial disk susceptibility testsA L Barry, D Amsterdam, M B Coyle, et al.
Pageof 9